LS5 & AssociatesLS5 & Associates Facebook ad: “Keytruda Health & Safety Update for Non-Smokers”
Ran for 29 days, from April 14 to May 13, 2026, the last day Crush saw it.
Run by LS5 & Associates on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1491710535632043
- Platforms
- Facebook and Instagram
- Relaunches
- 0
Ad text
Medical reports have highlighted a link between the immunotherapy drug Keytruda and serious, sudden-onset organ complications. While effective for many, certain patients have reported life-altering side effects involving the heart, kidneys, and nervous system. A legal investigation is reviewing cases of: Kidney or Renal Failure Heart Inflammation (Myocarditis) Severe Muscle Weakness (Myasthenia Gravis) Eligibility Criteria: This 60-second review tool is for patients who: ✅ Used brand-name Keytruda. ✅ Were not Stage 4 or terminal. ✅ Are non-smokers (if treated for lung cancer). Why this matters: When medical treatments lead to new health complications, families deserve to know their rights. This tool helps determine if the manufacturer may be responsible for medical bills and compensation. Click "learn more" for free and private case review.
Where the ad sends people
fb.me
Keytruda Health & Safety Update for Non-Smokers
Learn more: fb.me(opens in a new tab)
